0001209191-22-015024.txt : 20220302
0001209191-22-015024.hdr.sgml : 20220302
20220302181109
ACCESSION NUMBER: 0001209191-22-015024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220228
FILED AS OF DATE: 20220302
DATE AS OF CHANGE: 20220302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moran Michael Shawn
CENTRAL INDEX KEY: 0001886788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36306
FILM NUMBER: 22705602
MAIL ADDRESS:
STREET 1: C/O EAGLE PHARMACEUTICALS, INC.
STREET 2: 50 TICE BLVD., SUITE 315
CITY: WOODCLIFF
STATE: NJ
ZIP: 07677
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000827871
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
BUSINESS PHONE: 201-326-5300
MAIL ADDRESS:
STREET 1: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
FORMER COMPANY:
FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19880120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-28
0
0000827871
EAGLE PHARMACEUTICALS, INC.
EGRX
0001886788
Moran Michael Shawn
C/O EAGLE PHARMACEUTICALS, INC.
50 TICE BLVD., SUITE 315
WOODCLIFF LAKE
NJ
07677
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2022-02-28
4
A
0
10400
0.00
A
32115
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of February 28, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
/s/ Brian Cahill, Attorney-in-Fact
2022-03-02